FindTrial
Sign In

The effective BIS value research when remileron's separate sedation to inhibit the reaction of the tracheal intubation reactions of elderly patients

The effective BIS value research when remileron's separate sedation to inhibit the reaction of the tracheal intubation reactions of elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075915
Enrollment
Unknown
Registered
2023-09-19
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reaction of the tracheal intubation reactions

Interventions

Trail group:no

Sponsors

The first Affiliated Hospital of Sucoow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
80 Years to 92 Years

Inclusion criteria

Inclusion criteria: Incident: Gender is unlimited, 80 ~ 92 years old, American Society of Anesthesiology grades ? or III.

Exclusion criteria

Exclusion criteria: Elimination standards: combined with severe cardiovascular and cerebrovascular system diseases, severe allergies, 50kg 100 kg, previous abuse of anesthesia analgesic drugs, hearing impairment or language dysfunction, cognitive dysfunction, Mallampati class ? or ? ?, tensor <2.5 cm, double upper limb arterial blood pressure, and refuse to participate in this. Patients in clinical research.

Design outcomes

Primary

MeasureTime frame
Tracheal intubation response;—

Secondary

MeasureTime frame
MAPHRSpO2 ;The use of oxygen adrenaline and atropine, remedy the use of sedative drugs around Bofen;Changes in body temperature;Other bad events during and after surgery;—

Countries

China

Contacts

Public ContactLiu Sialn

The first Affiliated Hospital of Sucoow University

szliusl@126.com+86 135 8482 0752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026